News

Antibody Engineering and Therapeutics conference, San Diego, Dec 11 – 15 (booth#321)

ModiQuest Research, a leading custom antibody generation and development company, will be attending the Antibody Engineering and Therapeutics conference from December 11 till December 15 in San Diego. Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies … Continue reading

ModiQuest Research expands its antibody portfolio – get 30% discount!

Place your order for antibody MQR2.1201, MQR2.1301, MQR2.1401, MQR2.1501 and/or MQR2.1601 get a 30% introduction discount on these products (only in November and December 2017)!* ModiQuest Research BV today announced that it has expanded its antibody portfolio with five different  monoclonal human antibodies. These antibodies are highly specific and developed for the detection of the following targets: … Continue reading

Citryll-ModiQuest will present at 2017 ACR/ARHP Annual Meeting, in San Diego, November 03-08, 2017

Citryll – ModiQuest will present at 2017 ACR/ARHP Annual Meeting, in San Diego, November 03-08, 2017 A poster will be presented entitled “Expanded Therapeutic ACPA Utility for Different NET-Driven Human (Autoimmune) Diseases”. Abstract is available online at: http://acrabstracts.org/abstract/expanded-therapeutic-acpa-utility-for-different-net-driven-human-autoimmune-diseases/ Details of the session see below: Session Name: Innate Immunity and Rheumatic Disease Poster I Date and Session … Continue reading

ModiQuest at the European Antibody Congress in Basel, October 31 – November 2, 2017

ModiQuest Research, a leading custom antibody generation and development company, will be attending the Protein engineering summit from October 31 till November 2 in Boston. Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important … Continue reading

ModiQuest Research will be attending the PEGS conference, Boston, 1-5 May 2017

ModiQuest Research, a leading custom antibody generation and development company, will be attending the Protein engineering summit this May 1-5 in Boston. Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important antibody engineering step … Continue reading

ModiQuest Research acquired ’Crédit d’Impôt Recherche’, CIR

We are pleased to announce that ModiQuest Research has acquired ’Crédit d’Impôt Recherche’ (CIR) accreditation from the French Ministry of Higher Education and Research. The French R&D tax credit initiative gives eligible research-based French companies, who are subject to corporate tax in France, the ability to claim significant tax reduction on costs generated in R&D … Continue reading

ModiQuest Research will be attending the AET conference, San Diego, 11-15 December 2016

ModiQuest Research will be attending the AET conference ModiQuest Research, a leading custom antibody generation and development company, will be attending the Antibody Engineering and Therapeutics conference this December 11-15 in San Diego. There is a substantial interest in high-quality, functional antibodies against membrane spanning proteins, especially those considered intractable targets. Generating antibodies against these targets … Continue reading

ModiQuest Research will be attending the Milner Therapeutic Symposium, November 17

The inaugural Milner Therapeutics Symposium, From Basic Research to Drugs in Patients, will be held on 17 November 2016 at St. Catharine’s College, Cambridge. The Milner Therapeutics Symposium is a one day event that will bring together world-leading scientists in cancer biology, neurobiology, immunology and regenerative medicine with top companies from the pharmaceutical and biotechnology … Continue reading

Upcoming Webinar: ModiQuest Research and AstraZeneca, MD Anderson Cancer Center, share their screening and profiling strategies using the iQue Screener Platform

Amongst other subjects this webinar will overview: How ModiQuest Research maximized their chances of finding therapeutic leads by implementing the iQue Screener platform, speaker Andrea Gorlani, Ph.D., scientist. For more information see: Webinar Intellicyt  

Citryll will present on Annual European Congress of Rheumatology EULAR 2016 London, UK, 8 – 11 June 2016

Citryll will present on Annual European Congress of Rheumatology EULAR 2016 London, UK, 8 – 11 June 2016 Renato Chirivi, Ph.D. Head Internal Therapeutic development will be presenting at the 10th international congress on Autoimmunity, Leipzig, Germany. The conference will be held from 6-10 April. We will be presenting the latest data on Citryll’s NETosis … Continue reading

shopping basket 0 items

Shopping Cart

0

Your shopping cart is empty:

please visit the shop